163 related articles for article (PubMed ID: 27986127)
21. The Mediation Role of Thyrotropin Receptor Antibody in the Relationship Between Age and Severity of Hyperthyroidism in Graves' Disease.
Suzuki N; Inoue K; Yoshimura R; Kinoshita A; Suzuki A; Fukushita M; Matsumoto M; Yoshihara A; Watanabe N; Noh JY; Katoh R; Sugino K; Ito K
Thyroid; 2022 Oct; 32(10):1243-1248. PubMed ID: 36074931
[No Abstract] [Full Text] [Related]
22. Relationship between metabolic parameters and thyroid hormones and the level of gastric peptides in children with autoimmune thyroid diseases.
Sawicka B; Bossowski A; Szalecki M; Wysoka J; Koput A; Zelazowska-Rutkowska B; Tobolczyk J; Rogowski F; Łuba M
J Pediatr Endocrinol Metab; 2010 Apr; 23(4):345-54. PubMed ID: 20583539
[TBL] [Abstract][Full Text] [Related]
23. Serum immunoglobulin G4 levels and Graves' disease phenotype.
Martin CS; Sirbu AE; Betivoiu MA; Florea S; Barbu CG; Fica SV
Endocrine; 2017 Feb; 55(2):478-484. PubMed ID: 27819113
[TBL] [Abstract][Full Text] [Related]
24. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
[TBL] [Abstract][Full Text] [Related]
25. [Relationship between depression and thyroid hormone levels in patients with Graves disease].
Zeng J; Yan YR; Yan Z; Huang H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 May; 45(3):460-3, 470. PubMed ID: 24941818
[TBL] [Abstract][Full Text] [Related]
26. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
Kashiwai T; Tada H; Watanabe Y; Shimaoka Y; Yagoro A; Hidaka Y; Fujikado T; Amino N
Thyroid; 1998 Oct; 8(10):881-5. PubMed ID: 9827654
[TBL] [Abstract][Full Text] [Related]
27. Changes in Thyroid Hormone Levels Within the Normal and/or Subclinical Hyper- or Hypothyroid Range Do Not Affect Circulating Irisin Levels in Humans.
Panagiotou G; Pazaitou-Panayiotou K; Paschou SA; Komninou D; Kalogeris N; Vryonidou A; Mantzoros CS
Thyroid; 2016 Aug; 26(8):1039-45. PubMed ID: 27267080
[TBL] [Abstract][Full Text] [Related]
28. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
29. [Serum Myokines Levels in Patients with Endogenous Cushing Syndrome and Acromegaly: Cross-Sectional Case−Control Study].
Kolesnikova LI; Madaeva IM; Semenova NV; Osipova EV; Darenskaya MA
Vestn Ross Akad Med Nauk; 2016; 71(3):240-7. PubMed ID: 29297640
[TBL] [Abstract][Full Text] [Related]
30. Hyperthyroidism in Patients with Graves' Ophthalmopathy, and Thyroidal, Skeletal and Eye Muscle Specific Type 2 Deiodinase Enzyme Activities.
Molnár I; Szentmiklósi JA; Somogyiné-Vári É
Exp Clin Endocrinol Diabetes; 2017 Sep; 125(8):514-521. PubMed ID: 28750432
[TBL] [Abstract][Full Text] [Related]
31. Observations concerning the natural history of subclinical hyperthyroidism.
Woeber KA
Thyroid; 2005 Jul; 15(7):687-91. PubMed ID: 16053385
[TBL] [Abstract][Full Text] [Related]
32. A patient-specific treatment model for Graves' hyperthyroidism.
Pandiyan B; Merrill SJ; Di Bari F; Antonelli A; Benvenga S
Theor Biol Med Model; 2018 Jan; 15(1):1. PubMed ID: 29310665
[TBL] [Abstract][Full Text] [Related]
33. Hyperthyroidism is associated with higher plasma endothelin-1 concentrations.
Chu CH; Lee JK; Keng HM; Chuang MJ; Lu CC; Wang MC; Sun CC; Wei MC; Lam HC
Exp Biol Med (Maywood); 2006 Jun; 231(6):1040-3. PubMed ID: 16741045
[TBL] [Abstract][Full Text] [Related]
34. Decreased circulating levels of ANGPTL8 in Graves' disease patients.
Li H; Xu M; Zhao L; Xia H; Li Y; Hong X; Deng X; Yuan J; Ding Y; Guo C; Pan R; Wang D; Wang J; Yin W; Yang L; Yuan G
Hormones (Athens); 2019 Jun; 18(2):189-195. PubMed ID: 30900216
[TBL] [Abstract][Full Text] [Related]
35. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
Takasu N; Oshiro C; Akamine H; Komiya I; Nagata A; Sato Y; Yoshimura H; Ito K
J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248
[TBL] [Abstract][Full Text] [Related]
36. Serum levels of insulin-like growth factor 1 are negatively associated with log transformation of thyroid-stimulating hormone in Graves' disease patients with hyperthyroidism or subjects with euthyroidism: A prospective observational study.
Tseng FY; Chen YT; Chi YC; Chen PL; Yang WS
Medicine (Baltimore); 2019 Mar; 98(11):e14862. PubMed ID: 30882687
[TBL] [Abstract][Full Text] [Related]
37. Elevated Levels of Circulating Biomarkers Related to Leaky Gut Syndrome and Bacterial Translocation Are Associated With Graves' Disease.
Zheng D; Liao H; Chen S; Liu X; Mao C; Zhang C; Meng M; Wang Z; Wang Y; Jiang Q; Xue Y; Zhou L; Chen Y
Front Endocrinol (Lausanne); 2021; 12():796212. PubMed ID: 34975767
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for neonatal thyroid dysfunction in pregnancies complicated by Graves' disease.
Uenaka M; Tanimura K; Tairaku S; Morioka I; Ebina Y; Yamada H
Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():89-93. PubMed ID: 24726178
[TBL] [Abstract][Full Text] [Related]
39. Predictive value of bone turnover markers and thyroid indicators for bone metabolism in GD patients after treatment.
Su M; Chai J; Zheng W; Jia Q; Tan J; He Y; Zhang R; Men J; Liu W; Shi T; Ren J; Dong L; Liu L; Meng Z
Front Endocrinol (Lausanne); 2024; 15():1301213. PubMed ID: 38742199
[TBL] [Abstract][Full Text] [Related]
40. Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' disease.
Nagasaki T; Inaba M; Kumeda Y; Fujiwara-Ueda M; Hiura Y; Nishizawa Y
Biomed Pharmacother; 2007 Sep; 61(8):472-6. PubMed ID: 17420111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
